Evidence map›Paper›PMID 39086408›Full record

ArticleIranian journal of public health2024

Bone and Soft Tissue Sarcoma Epidemiology in Iranian Elderly Population; an Analysis of the Iranian National Registry for Cancer (2009-2014 Years).

Mohammad-Esmaeil Akbari, Mohammad Fararouei, Leila Asef Kabiri, Maryam Karami, Zahra Gheibi, Zahra Nikeghbalian, Afsaneh Maki, Mohammad Amin Bashirpour, Farid Moradian, Mousa Ghelichi-Ghojogh

Abstract read
In one paragraph

Article in Iranian journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammad-Esmaeil AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad FararoueiHIV/ADIS Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Leila Asef KabiriCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maryam KaramiDepartment of Reproductive Health Midwifery, School of Nursing & Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zahra GheibiDepartment of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra NikeghbalianDepartment of Reproductive Health Midwifery, School of Nursing & Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Afsaneh MakiCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Amin BashirpourCancer Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Farid MoradianDepartment of Surgery, School of Medicine, Alborz University of Medical Sciences, Alborz, Iran.
Mousa Ghelichi-GhojoghNeonatal and Children's Research Center, Department of Biostatistics and Epidemiology, School of Health, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We aimed to investigate the patterns of incidence and prevalence of bone sarcoma (BS) and soft tissue sarcoma (STS), morphology as well as geographical distribution in the elderly in Iran. Methods: By the primary site of the tumor and the morphological types, whole cases of cancer were classified. Then, the WHO classification (2018) and the third revision of the standard International Classification of Diseases for Oncology (ICD-O-3) were used to assign a code to them. The estimated incidence rates were obtained as the frequency of the newly-diagnosed cases within one year divided by the calculated population of the mid-year Iranian residents as estimated by the Iranian Bureau of Statistics. The age-standardized incidence rates were also estimated for both bone and soft tissue sarcoma. Results: The annual crude incidence rates of sarcomas in males (0.80 per 100,000) were more than in females (0.55 per 100,000) in all years. The total combined crude incidence in 2014 years was obtained at 0.67 per 100,000 people. In terms of disease grade majority of the patients were of grade 3 (11.5 %). In terms of tumor location, the Lower extremity was 16.8%, the Visceral (including gastrointestinal & uterus) 15.8%, the Thoracic 12.8%, and the Pelvic & abdominal wall 9.7%. Conclusion: Even though such sarcoma is more prevalent in elderly men, its incidence was also observed in lower-aged female groups. In addition, the incidence rate of BS was lower in comparison with that of STS, and the patients often exhibited an unknown degree of sarcoma.

Indexed as

Bone sarcomaElderlyEpidemiologyIranSoft tissue sarcoma

Identifiers

PMID39086408
PMCPMC11287597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.